Pure Global

TISENC Creatine Kinase-MB (CLIA) - Indonesia BPOM Medical Device Registration

TISENC Creatine Kinase-MB (CLIA) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101222269. The device is manufactured by SHENZHEN TISENC MEDICAL DEVICES CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. MITRA BAHAGIA CITRA MEDIKA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
TISENC Creatine Kinase-MB (CLIA)
Analysis ID: AKL 20101222269

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. MITRA BAHAGIA CITRA MEDIKA

AR Address

Jl. Raya Kalirungkut 27 Blok C-63

Registration Date

Dec 19, 2022

Expiry Date

Apr 21, 2027

Product Type

Clinical Chemistry Test System

Creatine phosphokinase/creatine kinase or isoenzymes test system(kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing